IBEX 35
10.854,70 -17,30 (-0,16%) Euro Stoxx 50
4.921,48 +30,87 (+0,63%) Dólar/Euro
1,0765 +0,0038 (+0,36%) Petróleo Brent
82,32 -0,71 (-0,86%) Oro
2.310,10 +0,50 (+0,02%) Bitcoin EUR
58.885,30 +223,03 (+0,38%)
10x Genomics, Inc. (TXG)
Después del cierre:
10x Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton, CA 94588-3260
United States
925 401 7300
https://www.10xgenomics.com
Sector(es): Healthcare
Sector: Health Information Services
Empleados a tiempo completo: 1259
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Serge Saxonov Ph.D. | Co-Founder, CEO & Director | 925,05k | 1,98M | 1977 |
| Dr. Benjamin J. Hindson Ph.D. | Co-Founder, President, Chief Scientific Officer & Director | 618,32k | 1,5M | 1975 |
| Mr. Justin J. McAnear | Chief Financial Officer | 587,41k | N/A | 1976 |
| Mr. Eric S. Whitaker Esq. | Chief Legal Officer | 615,38k | 3,19M | 1967 |
| Mr. Michael Schnall-Levin | Founding Scientist & CTO | N/A | N/A | N/A |
| Ms. Cassie Corneau | Manager of Investor Relations and Strategic Finance | N/A | N/A | N/A |
| Ms. Rebecca Port | Chief People Officer | N/A | N/A | N/A |
| Mr. Jens Durruthy | Associate Director of Product Management | N/A | N/A | N/A |
Descripción
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Gobierno corporativo
El ISS Governance QualityScore de 10x Genomics, Inc., a día 1 de mayo de 2024, es 10. Las puntuaciones base son Auditoría: 4; Tablero: 7; Derechos de los accionistas: 10; Compensación: 10.
